Rapport Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating income | −$36.2M | −$83.1M | −$125.1M |
| Net income | −$34.8M | −$78.3M | −$111.5M |
| Operating cash flow | −$27.2M | −$64.8M | −$87.5M |
| Free cash flow | −$28.8M | −$67.2M | −$88.1M |
| Cash | $70.2M | $56.8M | $52.6M |
| Shares outstanding | 4.2M | 36.6M | 47.8M |